Comments

Metagenomi Stock Price, Quotes and Forecasts

Q: What sector and industry does Metagenomi (MGX) operate in?

Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MGXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.48

0.021.37%

At close: -

$1.55

0.074.73%

After Hours: 6:02 PM EDT

Metagenomi (MGX) Forecast

News Earnings Metagenomi (MGX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Metagenomi Stock Price, Quotes and Forecasts | NASDAQ:MGX | Benzinga

Explore Metagenomi stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MGX.

Open	$1.45
Close	$1.48
Volume / Avg.	329.80K / 399.35K
Day Range	$1.41 - $1.54
52 Wk Range	1.23 - 5.63
Market Cap	$57.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.84%
Days to Cover	8.41

Recent News

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.

Vandana Singh

Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.45
Close	$1.48
Volume / Avg.	329.80K / 399.35K
Day Range	$1.41 - $1.54
52 Wk Range	1.23 - 5.63
Market Cap	$57.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	7.84%
Days to Cover	8.41

About Metagenomi Inc.

Sector

Health Care

Industry

Biotechnology

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for pati...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Metagenomi (MGX) stock?

You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.

View our list of the best stock brokerages

Who are Metagenomi (MGX) competitors?

Other companies in Metagenomi’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and OS Therapies (AMEX:OSTX).

What is the forecast, or price target, for Metagenomi (MGX) stock?

Metagenomi has a consensus price target of $13.50.

What is the current price for Metagenomi (MGX)?

The stock price for Metagenomi (NASDAQ: MGX) is $1.55 last updated June 18, 2025 at 6:02 PM EDT.

Does Metagenomi (MGX) pay a dividend?

There are no upcoming dividends for Metagenomi.

When is Metagenomi (NASDAQ:MGX) reporting earnings?

Metagenomi’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Metagenomi (MGX) going to split?

There is no upcoming split for Metagenomi.

What sector and industry does Metagenomi (MGX) operate in?

Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.